In particular, the combination of HSP70, ENO1 and RNH1 autoantibodies reactivities represent a good candidates as a new biomarker for CCA and should thus be investigated in a large-scale prospective study in high-risk subjects such as liver fluke infected Thai subjects. This evidence concerns the gene ENO1 and cholangiocarcinoma.